Soren M. Johnson, Ph.D.
Affiliations: | 2010 | Genetics & Molecular Biology | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Soren Johnson"Parents
Sign in to add mentor| Norman E. Sharpless | grad student | 2010 | UNC Chapel Hill | |
| (Genetic and pharmacologic regulation of cyclin dependent kinase 4 and 6 activity in mammalian hematopoiesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Roberts PJ, Usary JE, Darr DB, et al. (2012) Combined PI3K/mTOR and MEK inhibition provides broad antitumor activity in faithful murine cancer models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5290-303 |
| Liu Y, Johnson SM, Fedoriw Y, et al. (2011) Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood. 117: 3257-67 |
| Monahan KB, Rozenberg GI, Krishnamurthy J, et al. (2010) Somatic p16(INK4a) loss accelerates melanomagenesis. Oncogene. 29: 5809-17 |
| Johnson SM, Torrice CD, Bell JF, et al. (2010) Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. The Journal of Clinical Investigation. 120: 2528-36 |